Results 161 to 170 of about 25,222 (249)

Contributions of the interaction between mu-opioid receptors and dopamine receptors in the regulation of risky decision making. [PDF]

Prog Neuropsychopharmacol Biol Psychiatry
Kahanek P, Opachich Z, Csitkovits I, Kelly M, Orsini CA.   +4 more
europepmc   +1 more source

Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2623-2638, September 2026.
ABSTRACT Primary biliary cholangitis (PBC) is an autoimmune liver disease that targets the small intrahepatic bile ducts with diagnosis based on elevated serum alkaline phosphatase (ALP) levels and the presence of anti‐mitochondrial antibodies. Untreated, it may run a progressive course to cirrhosis and hepatic decompensation, at which point liver ...
Simone I. Strasser, Alexander J. Thompson, Rohit Gupta, John Lubel, Janine French, Beverly Sacks, Martin Weltman   +6 more
wiley   +1 more source

The Use of Naltrexone to Successfully Treat Severe Hailey-Hailey Disease. [PDF]

Cureus
Mehrabian F, Vaughan E, Abid M, Gandhi N, Hawari R.   +4 more
europepmc   +1 more source

Long‐term outcomes in patients with postural orthostatic tachycardia syndrome with an average follow‐up of over 20 years

Journal of Internal Medicine, Volume 300, Issue 3, Page 299-311, September 2026.
Abstract Background Postural orthostatic tachycardia syndrome (POTS) is a chronic form of orthostatic intolerance that primarily affects female patients. There are scarce data evaluating the long‐term outcomes in POTS. Objectives This study sought to evaluate the long‐term impacts of POTS over multiple decades in adult patients.
Kate M. Bourne, Alfredo Gamboa, Bonnie Black, Juliette Hall, Italo Biaggioni, Cyndya A. Shibao, André Diedrich, Amanda Peltier, Giris Jacob, Luis Okamoto, Robert S. Sheldon, Satish R. Raj   +11 more
wiley   +1 more source

How do services offered within opioid treatment programs vary based on state methadone policies? [PDF]

J Subst Use Addict Treat
Lindenfeld Z, Krawczyk N, Taylor EA, Agniel D, Cantor JH.   +4 more
europepmc   +1 more source

Concerns with the statistical analysis in "Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study". [PDF]

Int J Obes (Lond)
Mokalla TR, Robertson HT, Pals S, Allison DB.   +3 more
europepmc   +1 more source

Naltrexone and Nalmefene as Modern Psychopharmacotherapy for Alcohol Use Disorder: Modulation of Opioid Receptors and Neurobiological Pathways of Alcohol Action. [PDF]

Biomedicines
Rząca M, Sroka M, Fus K, Ślebioda D, Kozinska R, Chmiela M, Chłopaś-Konowałek A.   +6 more
europepmc   +1 more source

The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID. [PDF]

Ment Health Clin
Pucci SL, Veide A, Pierce H, Kaminski D.
europepmc   +1 more source

Morphine and nicotine intake in high drinking in the dark mice is reduced by informatics-nominated and translationally relevant compounds. [PDF]

Front Psychiatry
Ginder DE, Palacios J, Stewart M, Jensen BE, Borrego MB, Tzab L, Ozburn AR.   +6 more
europepmc   +1 more source

Discontinuation of medications for alcohol use disorder in the United States: Patient, prescriber and medication predictors. [PDF]

Addiction
Busch AB, Hodgkin D, Kennedy-Hendricks A, Ritter GA, Uscher-Pines L, Horgan CM, Huskamp HA.   +6 more
europepmc   +1 more source